Series A - Luminopia

Series A - Luminopia

Investment Firm

Overview

Luminopia develops a new class of treatments for significant neuro-visual disorders.

Announced Date

Jun 27, 2023

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

U.S. Venture Partners

U.S. Venture Partners

U.S. Venture Partners is a early_stage_venture and late_stage_venture and venture firm.

Participant Investors

2

Investor Name
Participant InvestorThe Vertical Group
Participant InvestorU.S. Venture Partners

Round Details and Background

Luminopia raised $16000000 on 2023-06-27 in Series A

Luminopia develops a new class of treatments for significant neuro-visual disorders.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 01, 2020
Seed Round - Luminopia
1-4.8M
Nov 01, 2019
Pre Seed Round - Luminopia
2-5.7M
Nov 11, 2022
Seed Round - Luminopia
4-5.7M
Jun 27, 2023
Series A - Luminopia
4-16.0M

Recent Activity

There is no recent news or activity for this profile.